In recent years, comprehensive transcriptional profiling studies have revealed four intrinsic biological subtypes of breast cancer, defined as luminal A, luminal B, HER2 enriched and basal-like, which have been shown to be robust for predicting treatment sensitivity and survival outcomes [18]. This evidence concerns the gene ERBB2 and breast cancer.